Recruitment of primitive peripheral blood cells: Synergism of interleukin 12 with interleukin 6 and stromal cell-derived factor-1

被引:16
作者
Grafte-Faure, S
Leveque, C
Ketata, E
Jean, P
Vasse, M
Soria, C
Vannier, JP
机构
[1] Res Dept Microenvironm & Cell Integrated Renewal, F-76183 Rouen, France
[2] IFR Physicochem & Biol Integrated Syst, CNRS 61, Mont St Aignan, France
关键词
5-FU; haematopoietic stem cell; human; peripheral blood; IL-12; IL-6; SCF; SDF-1;
D O I
10.1006/cyto.1999.0520
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In bone marrow, haematopoietic stem cells (HSC) rely On close contact with stromal cells for proliferation and differentiation. Stromal cell-derived factor (SDF-1) is a chemokine produced by bone marrow stromal cells and has been reported to be a chemoattractant for CD34(+) cells; SDF-1 was evaluated for effects oh proliferation of both mature and immature human progenitor cells in vitro. Neither proliferation nor maturation of peripheral blood cells was stimulated by SDF-1 alone. Moreover, we have previously demonstrated that 5-fluorouracile (5-FU) resistant HSC require a combination of interleukin 12 (IL-12), IL-6 and SCF for the production of morphologically recognizable clonogenic elements at day 14 in semisolid medium. Our data reported a strong enhancement of the IL-6, IL-12, SCF-induced synergism (172%) by SDF-1 (296.5%). Furthermore, our data suggest that this chemokine alone had no effect on triggering quiescent cells and may preserve these cells from 5-FU cell damage or upregulate early-acting cytokine receptors, Thus, SDF-1 might play a key role in early human haematopoiesis through its potent synergistic effects in combination with early-acting cytokines, These results suggest that a programmed response to sequential cytokine stimulation may be part of a control mechanism required for maintenance of proliferation of primitive HSC. (C) 2000 Academic press.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 43 条
  • [1] The chemokine SDF-1 is a chemoattractant for human CD34(+) hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34(+) progenitors to peripheral blood
    Aiuti, A
    Webb, IJ
    Bleul, C
    Springer, T
    GutierrezRamos, JC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01) : 111 - 120
  • [2] BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
  • [3] Chemokines and leukocyte traffic
    Baggiolini, M
    [J]. NATURE, 1998, 392 (6676) : 565 - 568
  • [4] The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
    Bleul, CC
    Farzan, M
    Choe, H
    Parolin, C
    ClarkLewis, I
    Sodroski, J
    Springer, TA
    [J]. NATURE, 1996, 382 (6594) : 829 - 833
  • [5] A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
    Bleul, CC
    Fuhlbrigge, RC
    Casasnovas, JM
    Aiuti, A
    Springer, TA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) : 1101 - 1109
  • [6] BROXMEYER HE, 1995, ANN HEMATOL, V71, P235, DOI 10.1007/s002770050112
  • [7] BROXMEYER HE, 1993, J IMMUNOL, V150, P3448
  • [8] MONOCYTE CHEMOATTRACTANT PROTEIN-1 ACTS AS A T-LYMPHOCYTE CHEMOATTRACTANT
    CARR, MW
    ROTH, SJ
    LUTHER, E
    ROSE, SS
    SPRINGER, TA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) : 3652 - 3656
  • [9] Functional heterogeneity of human CD34(+) cells isolated in subcompartments of the G(0)/G(1) phase of the cell cycle
    Gothot, A
    Pyatt, R
    McMahel, J
    Rice, S
    Srour, EF
    [J]. BLOOD, 1997, 90 (11) : 4384 - 4393
  • [10] Grafte S, 1998, AM J HEMATOL, V58, P183, DOI 10.1002/(SICI)1096-8652(199807)58:3<183::AID-AJH4>3.0.CO